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Abstract: Immunosenescence is considered a major contributory factor to the increased frequency of morbidity and mortality among 
elderly. On the other hand centenarians are considered the best example of successful ageing. To gain insight into mechanisms of 
immunosenescence and its clinical relevance, a possible model is represented by centenarians and/or their offspring. Nowadays 
centenarians are not more a curiosity, but in Europe are 1/8000 inhabitants and it has been demonstrated that the centenarian offspring, 
who are typically in their 70s and 80s, have a survival advantage when compared with age-matched controls whose parents died at an 
average life expectancy. Then again, studies on immunosenescence focus mainly on T cell impairment, although B cells are also affected. 
So, in the present preliminary report, we have studied B cell compartment in two classes of individuals, old people and centenarian 
offspring. B cell compartment was analysed using anti-IgD and CD27 antibodies which characterize naïve B cells (IgD+ CD27-), memory 
unswitched B cells (IgD+CD27+), memory switched B cells(IgD-CD27+) and double negative B cells (DN) (IgD-CD27-), i.e. exhausted 
memory cells. As expected, in both cohorts we observed a decreased B cell count. However, in centenarian offspring, naïve B cells are 
more abundant whereas exhausted memory cells (DN B cells, IgD-CD27-) do not show the increase that we have previously demonstrated 
in healthy elderly donors. These data are similar to that found in previously experiments on young subjects. So, our preliminary results 
show that centenarian offspring do not have the typical trend of memory/naive B cell subsets observed in elderly people and this is in 
agreement with the higher levels of IgM in the serum of centenarian offspring in comparison with data obtained in age-matched controls. 
This reservoir of naive B cell might be one of the causes that make centenarian offspring able to keep fighting off new infections, hence 
prolonging their life. So, B cell subset changes could represent a hallmark of successful or unsuccessful ageing and could be used as a 
biomarker of human life span, potentially useful for the evaluation of anti-ageing treatment. 
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INTRODUCTION 
 Immunosenescence is considered a major contributory factor to 
the increased frequency of morbidity and mortality among elderly. 
It renders elderly increasingly susceptible to infectious diseases, 
leads to resurgence of latent infections, and also to infection by 
opportunistic organisms. These infections contribute significantly to 
morbidity in this age-group, and frequently lead to irreversible 
frailty and dependency. In addition, there is a decline in the 
protective effect of vaccination in the elderly [1-7]. Lifelong and 
chronic antigenic load seem to be the major driving force of 
immunosenescence, which impacts on human lifespan by reducing 
the number of virgin antigen-non experienced cells, and, simul-
taneously, filling the immunological space with expanded clones of 
memory and effector, antigen-experienced cells [7-9]. On the other 
hand, it has been demonstrated that centenarians escape the main 
diseases typical of aged and show well preserved immune func-
tions. In fact immunosenescence is a complex process in which 
different immunological functions are remodeled and centenarians 
are an impressive demonstration of this phenomenon [10,11]. 
 Prolongation of life expectancy has represented one of the 
humanity’s greatest triumph in the 20th century. This unprece-
dented success is now one of society’s greatest challenges. Impro-
ved child survival, reduced mortality rates, and decreasing fertility 
rates worldwide, is resulting in a rapid ageing of the world’s 
population. This ageing is evident worldwide, and particularly 
evident in developing countries where the elderly population is 
predicted to quadruple over the next 25 years at which time it will 
represent over 25% of the total population. In particular, around the 
60's in all the industrialized countries the progressive decline of the 
mortality (-2% year) in individuals over-80 years old has risen up of 
about twenty times the number of oldest old people. This has  
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increased the number of centenarians that nowadays are not more a 
curiosity, but in Europe are 1/8000 inhabitants [10,12,13]. 
 Furthermore, centenarians are considered the best example of 
successful ageing [10,11]. To gain insight into mechanisms of 
immunosenescence and its clinical relevance, a possible model is 
represented by centenarians and/or their offspring. In fact, it has 
been demonstrated that the centenarian offspring, who are typically 
in their 70s and 80s, have a survival advantage when compared 
with age-matched controls whose parents died at an average life 
expectancy. Centenarian offspring, like their centenarian parent(s), 
have genetic and functional advantages associated with lower 
cardiovascular disease risk [14,15]. These findings support the 
hypothesis that centenarian offspring are predisposed to healthy 
aging and longer survival, making them a suitable target of ageing 
studies, because, unlikely of centenarians, they have an appropriate 
control group, i.e. common elderly. 
 Literature of immunosenescence has focused mainly on T cells, 
although B cell compartment is also affected in aged. Changes in B 
cell number and repertoire have been described and data in 
literature demonstrate that elderly frequently do not have protective 
antibody concentrations against recall antigens so suggesting the 
impairment of B cell branch [16,17]. The aim of this study was to 
compare some B cell parameters between healthy centenarian 
offspring and healthy age-matched controls to evaluate whether any 
difference exists in the naïve/memory B cell compartment that 
might explain the familiar increased lifespan expectancy of 
centenarian offspring. So, in the present preliminary report, we 
have studied B cell compartment in two classes of individuals, old 
people and centenarian offspring. B cell compartment was analyzed 



















), i.e. exhausted memory cells [18,19]. In fact we 
have recently demonstrated an increase of late (exhausted) memory 
B cells in elderly [20] also accompanied by a decrease of serum 
IgM, so confirming the loss of naïve cells/products (i.e. antibodies) 
in the elderly [21]. Here we show that centenarian offspring have an 
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increased amount of naïve B cells and IgM when compared to their 
controls, whereas we do not observe the increase of DN B cells 
shown in healthy elderly people.  
MATERIALS AND METHODS 
 Twenty-nine Sicilian centenarian offspring (CO, age range 59-
83, mean 73.4 ± 7 years), with almost one of their parents 
centenarian (>99 years), whose age had been confirmed from 
records at the city hall and/or church registries, were studied. A 
total of 25 age-matched Sicilian controls (A-M) (age range 60-85, 
mean 78.6 ± 4.7 years) were also included in the study. All subjects 
were in good health according to their clinical history and blood 
tests (complete blood cell count, erythrocyte sedimentation rate, 
glucose, urea nitrogen, creatinine, electrolytes, C reactive protein, 
liver function tests, iron, proteins). The study received approval 
from local ethic committee and all participants gave their informed 
consent. 
 Peripheral blood mononuclear cells (PBMCs) were isolated 
from heparinized venous blood by density gradient centrifugation 
on Ficoll-Lympholyte (Cedarlane Laboratories Limited, Ontario, 
Canada). PBMCs were adjusted to 1 x 10
6
 /ml in RPMI 1640 
medium (Euroclone, Devon, UK) supplemented with 10% heat-
inactivated fetal calf serum (Euroclone), 1% penicillin/streptomicin, 
10 mM HEPES, and 1 mM L-glutamine. 
 In order to evaluate the lymphocytes subsets, total PBMCs were 
stained with different combinations of the following monoclonal 
antibodies: anti-CD3, anti-CD4, anti-CD8, anti-CD16, anti-CD19. 
All the antibodies were directly coupled either to fluorescein 
isothiocyanate (FITC), phycoerytrin (PE) or PE-Cy7 (Pharmingen, 
BD Bioscience, Mountain View, CA, USA). To analyze B cell 
subsets, PBMCs were stained with the following monoclonal anti-
bodies combination: anti-CD19FITC, anti-IgDPE and anti-CD27APC 
(Pharmingen).  
 All measurements were made with a FACSCalibur flow 
cytometer (Becton Dickinson, San Jose, CA, USA) with the same 
instrument setting. At least 10
4
 cells were analyzed using CellQuest 
Pro (Becton Dickinson, San Jose, CA, USA) software. 
 For IgG, IgA and IgM assay, the serum of all subjects was 
stored in aliquots at -80°C until analysis and the immunoglobulin 
concentrations were determined by Integra 800 (Roche Diagnostics, 
Milan, Italy) according to manufacturer instructions. 
 Values, given as the mean ± SD, were compared using one-way 
analysis of variance (ANOVA). Differences were considered 
significant when a p value < 0.05 was obtained by comparison 
between the different groups. 
RESULTS 
 In Table 1 we report the percentage and absolute number of 
lymphocyte subpopulations evaluated in 29 centenarian offspring 
(age range 59-83 years, mean age 73.4 ± 7 years) and 25 healthy 
age-matched controls (age range 60-85, mean 78.6 ± 4.7). As 
shown no significant differences have been observed between the 
lymphocyte values in the two groups studied. 
 So, concerning these lymphocyte subsets, centenarian offspring 
behave as the common elderly population.  
 Regarding naïve/memory B cell subsets, we analysed circula-
ting CD19
+
 lymphocytes obtained by peripheral blood of 
centenarian offspring and their age-matched controls on the basis of 
the expression of IgD and CD27 into different functional subsets. 



















), i.e. exhausted memory cells [20] [Fig. (1) shows 
a characteristic plot]. 
 In Table 2 we report the percentage and absolute number of 
these B lymphocyte subpopulations. As shown, the percentage and 




 naïve B cells are significantly 
increased in centenarian offspring when compared to age-matched 










 B cells, i.e. exhausted memory cells, are significantly 
reduced in centenarian offspring. So, concerning these B cell 
subsets, centenarian offspring behave as the young population [20].  
 This observation is strengthened by serum immunoglobulin 
measurement. In fact, as displayed in Fig. (2), the concentration of 
IgM, a marker of the primary response, shows significant higher 
levels in centenarian offspring when compared to age-matched 
controls, whereas IgG and IgA levels are not significantly different 
between the two groups. 
DISCUSSION 
 Ageing is a natural process that occurs in all cells, tissues, 
organs and organisms. It is modulated by both genetic and 
environmental factors. One of the most important characteristics of 
ageing is immunosenescence, that is the consequence of the conti-
nuous attrition caused by chronic antigenic load. The antigenic load 
results in the progressive generation of inflammatory responses 
involved in age-related diseases [8,9,22]. In the elderly many 
alterations of both innate and acquired immunity, have been 
described. The acquired compartment of immune system shows 
significant modifications in the elderly, in fact both T and B 
 
 
Table 1. Lymphocyte Subpopulations in 29 Centenarian Offspring (CO, Mean Age 73.4 Years, Age Range 59-83) and 25 Age-
Matched Controls (A-M, Mean Age 78,6 Years, Age Range 60-85). Data are Expressed as Mean ± SD of Absolute Numbers 












CD3+ 68.4±12.2 64.9±10.8 0.1 1483±494 1352±360 0.3 
CD4+ 46.2±11.4 44.1±10.1 0.2    952±421   875±224 0.4 
CD8+ 20.8±7.0 18.8± 7.2 0.3    402±190   429±228 0.6 
CD19+   7.7±3.8 10.2± 6.1 0.3    152±107    106±97 0.1 
CD3-CD16+ 12.1±7.3 12.6± 5.7 0.3    277±184    267±149 0.8 
p= values of CO vs. A-M. 
 

















Fig. (1). Density Plot of memory/naïve B cells distribution. B subpopulations are identified by the expression of IgD and CD27 in centenarian offspring (A) 
and age-matched controls (B). the analysis of Figure refers to cells gated as CD19+. 
 
Table 2. B Cell Subsets of 29 CO Subjects, 25 A-M Controls as Analyzed According to the Expression of IgD and CD27. Data are 
Expressed as Mean ± SD of Absolute Numbers and Percentage. Significance has been Evaluated by ANOVA Test 











IgD+CD27- 49.5±18.3 36.1±17.8 0.01 79.5±75.4 43.0±41.0 0.04 
IgD+CD27+ 15.6±10.5 24.1±14.7 0.02 23.7±20.3 28.3±32.2 0.5 
IgD-CD27+ 26.0±15.4 22.9±10.9 0.4 37.2±27.3 24.1±25.9 0.1 
IgD-CD27- 8.3±5.1 15.0±9.2 0.003 10.3±7.0 18.6±28.6 0.1 






















Fig. (2). Analysis of IgG, IgA and IgM serum concentrations in centenarian offspring (CO) and age-matched controls (A-M). 
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lymphocytes are reduced and, in T cell compartment, memory T 
cells are increased [1,8,9,19,23]. Furthermore, the study of 
centenarian immune systems has revealed that several immune 
parameters are well conserved, suggesting that a complex remo-
delling of most immune parameters occurs with age [10,11].  
 In our paper, we have gained insight into the B cell 
compartment of centenarian offspring and in particular into the 
memory/naïve B cell branch, comparing our data to those obtained 
in healthy age-matched controls. We believe that our data, though 
preliminary, are of some interest as in centenarian offspring we do 
not observe the typical naïve-memory shift observed in elderly [20]. 
Moreover, comparing these data with data recently published by 
our group we observe that CO behave as young controls [20]. Also 
the evaluation of IgM secreted in the serum by CO shows that the 
values are within the range of the levels observed in young subjects 
as published by our group few years ago [21]. So, on the whole 
naïve B cells are well represented in CO compared with the AM 
controls, suggesting a good bone marrow cell reservoir. This is an 
interesting observation, as it has been recently reviewed [24] the 
bone marrow ability to generate B cells is impaired with age. The 
mirror image of this is the reduced amount of the primed/memory 
pool in centenarian offspring. In particular, here we report that in 
centenarian offspring we do not observe the increase of DN (IgD-
CD27-) B cells. As we and others have recently suggested [20,25], 
these are memory B cells that lack the typical memory marker 
CD27, and are so considered to be late-memory B cells, i.e. 
exhausted ones. It is interesting to observe that these cells are 
expanded both in elderly [20] and in patients suffering of chronic 
immune inflammation as SLE [25,26], so suggesting that the 
antigenic load or the “inflammatory” environment play a central 
role in the exhaustion of the B cell branch too.  
 It is known that memory and naive B cells produce different 
cytokines. Naive and memory B cells also express different Toll-
like receptors and so they have a regulatory role in the chronic 
infections against viruses and bacteria also producing cytokines and 
chemokines. This suggests that the immune-inflammation is also 
related to the B cell branch of the immune system in aged people 
since they are able to produce different chemokines and cytokines 
[27-30]. Hence, these studies are relevant both to instructive 
immunity and inflammation-related diseases typical of aged people. 
 All together these data support the hypothesis of a “familiar 
youth” of the immune system that can be a big advantage both to 
fight the main age-related diseases and to properly respond to 
vaccinations. In particular, the reservoir of naive B cell might be 
one of the causes that make centenarian offspring able to keep 
fighting off new infections, hence prolonging their life. So, B cell 
subset changes could represent an hallmark of successful or 
unsuccessful ageing and could be used as a biomarker of human life 
span, potentially useful for the evaluation of anti-ageing treatment 
[31,32]. 
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ABBREVIATIONS  
A-M = Age-Matched Sicilian controls 
APC = Allo-Phyco-Cyanin 
CO = Centenarian Offspring 
DN = Double Negative  
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